Analyst Ratings for ESSA Pharma (EPIX)

EPIX Rating Summary

  |   Expand Research on EPIX
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 3.3 / 10   Percentile Rank: 30%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
12/16/2024 Bloom Burton & Co. David Martin New Coverage Hold (3)
(N/A)		 2.25
(N/A)		 1.64
(0.20)		 -87.8% Details
11/4/2024 Piper Sandler Joseph Catanzaro Downgrade Neutral
(Overweight)		 2.00
(15.00)		 5.20
(0.20)		 -96.15% Details